Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2011 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Interest Coverage Ratio of 0.26 for Q2 2026, up 101.66% year-over-year from 0.13 in Q2 2025, and down 20.71% on a QoQ basis from 0.33 in Q1 2026.
Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Interest Coverage Ratio for 15 years, with the latest figure at 0.26 in Q2 2026.
- Interest Coverage Ratio for Q2 2026 came in at 0.26, up 101.66% year-over-year; the trailing twelve-month figure through Jun 2026 was 1.36 (down 91.68% YoY), and the FY2025 annual result was 6.36, up 25.14% from the prior year.
- Interest Coverage Ratio retreated to 0.26 in Q2 2026, from 0.33 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 79.11 in Q4 2023 and troughed at 15.66 in Q2 2025.
- A 5-year average of 11.83 and a median of 0.95 in 2022 frame the typical range for Interest Coverage Ratio.
- The widest annual swing landed in 2022, when Interest Coverage Ratio surged 985.17%; it then slumped 4202.41% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 9.49 in 2022, then surged by 733.89% to 79.11 in 2023, then slumped by 94.3% to 4.51 in 2024, then surged by 387.33% to 21.97 in 2025, then sank by 98.82% to 0.26 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.26 in Q2 2026, 0.33 in Q1 2026, and 21.97 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26 |
| Mar 31, 2026 | 0.33 |
| Dec 31, 2025 | -7.48 |
| Sep 30, 2025 | 0.39 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 2.54 |
| Dec 31, 2024 | -6.34 |
| Sep 30, 2024 | 5.13 |
| Jun 30, 2024 | 0.38 |
| Mar 31, 2024 | 16.28 |
| Dec 31, 2023 | 9.39 |
| Sep 30, 2023 | 41.53 |
| Jun 30, 2023 | 3.08 |
| Mar 31, 2023 | -6.84 |
| Dec 31, 2022 | -18.46 |
| Sep 30, 2022 | 73.17 |
| Jun 30, 2022 | 24.86 |
| Mar 31, 2022 | 0.78 |
| Dec 31, 2021 | -5.50 |
| Sep 30, 2021 | 6.74 |